- Home
- EMBC vs BVS Comparison
EMBC vs BVS Comparison
Compare EMBC & BVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EMBC
- BVS
- Stock Information
- Founded
- EMBC 1924
- BVS 2011
- Country
- EMBC United States
- BVS United States
- Employees
- EMBC N/A
- BVS N/A
- Industry
- EMBC Medical/Dental Instruments
- BVS Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- EMBC Health Care
- BVS Health Care
- Exchange
- EMBC Nasdaq
- BVS Nasdaq
- Market Cap
- EMBC 753.0M
- BVS 883.7M
- IPO Year
- EMBC N/A
- BVS 2021
- Fundamental
- Price
- EMBC $14.62
- BVS $11.24
- Analyst Decision
- EMBC Sell
- BVS Strong Buy
- Analyst Count
- EMBC 1
- BVS 2
- Target Price
- EMBC $12.00
- BVS $16.00
- AVG Volume (30 Days)
- EMBC 247.0K
- BVS 489.1K
- Earning Date
- EMBC 11-26-2024
- BVS 11-05-2024
- Dividend Yield
- EMBC 4.10%
- BVS N/A
- EPS Growth
- EMBC 45.34
- BVS N/A
- EPS
- EMBC 1.20
- BVS N/A
- Revenue
- EMBC $1,118,900,000.00
- BVS $555,061,000.00
- Revenue This Year
- EMBC $1.45
- BVS $11.24
- Revenue Next Year
- EMBC $0.53
- BVS $6.77
- P/E Ratio
- EMBC $12.17
- BVS N/A
- Revenue Growth
- EMBC 0.48
- BVS 10.40
- 52 Week Low
- EMBC $9.93
- BVS $3.67
- 52 Week High
- EMBC $19.79
- BVS $14.38
- Technical
- Relative Strength Index (RSI)
- EMBC 48.99
- BVS 41.28
- Support Level
- EMBC $14.81
- BVS $7.30
- Resistance Level
- EMBC $16.19
- BVS $12.61
- Average True Range (ATR)
- EMBC 0.68
- BVS 0.97
- MACD
- EMBC 0.02
- BVS -0.25
- Stochastic Oscillator
- EMBC 27.69
- BVS 55.65
About EMBC Embecta Corp.
Embecta Corp is a medical technology company. The company develops innovative technology, services, and solutions that help advance both clinical therapy for patients and clinical processes for healthcare providers. Its products include BD Pyxis, PureWick, Phasix among others.
About BVS Bioventus Inc.
Bioventus Inc is a medical technology company. The company is engaged in developing and commercializing clinically differentiated treatments that engage and enhance the body's natural healing process. It offers a diverse portfolio of products to serve physicians spanning the orthopedic continuum, including sports medicine, total joint reconstruction, hand and upper extremities, foot and ankle, podiatric surgery, trauma, spine and neurosurgery. Its portfolio of products is grouped into three verticals based on clinical use: Pain Treatments, Surgical Solutions, and Restorative Therapies. Geographical presence is in the United States which derives key revenue, and International markets.